Skip to main content
BioGaia logo

BioGaia — Investor Relations & Filings

Ticker · BIOG ISIN · SE0017769995 LEI · 549300UBUJOY2L7TT361 ST Manufacturing
Open in API
Filings indexed 610 across all filing types
Latest filing 2023-05-05 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BIOG

About BioGaia

https://www.biogaia.com/

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsredogörelse' (Interim Report) for BioGaia AB covering the period January to March 2023. It contains detailed financial statements, segment analysis (Barnhälsa and Vuxenhälsa), management commentary, and key performance indicators. It is not an announcement of a report, but the report itself, containing substantive financial data. Q1 2023
2023-05-05 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim management statement' for BioGaia AB covering the period January–March 2023 (Q1). It contains detailed financial statements, including net sales, operating profit, earnings per share, and balance sheet data, as well as management commentary on business performance. It is a comprehensive quarterly report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-05 English
BioGaias resultat för första kvartalet överstiger marknadens förväntningar
Earnings Release Classification · 100% confidence The document provides preliminary financial results for the first quarter (Q1) of 2023, including sales (366 MSEK) and operating profit (148 MSEK), and explicitly states that the full interim report ('delårsredogörelsen') will be published on May 5, 2023. This text is a high-level summary of key financial figures released ahead of the comprehensive report. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not the full Interim Report (IR) itself, nor is it a general regulatory announcement (RNS) since it has a specific financial focus. Q1 2023
2023-04-26 Swedish
BioGaia’s results for the first quarter to exceed market expectations
Earnings Release Classification · 98% confidence The document provides preliminary financial highlights for the first quarter, including sales (SEK 366 million) and operating profit (SEK 148 million), explicitly stating that the full 'interim report for the first quarter 2023' will be published later (May 5, 2023). Since this text contains key financial results for a period shorter than a year (Q1) but is not the comprehensive report itself, it fits the definition of an Earnings Release (ER). It announces the results before the full Interim Report (IR) is released. The length is short, suggesting an initial announcement rather than the full report. Q1 2023
2023-04-26 English
Kallelse till årsstämma i BioGaia AB (publ)
AGM Information Classification · 100% confidence The document is titled "Kallelse till årsstämma i BioGaia AB (publ)" which translates to "Notice of Annual General Meeting in BioGaia AB (publ)". It details the date, time, location, registration procedures, proposed agenda (including election of directors, approval of financial statements, and dividend proposals), and specific proposals for shareholder votes. This content is characteristic of a formal notice and materials distributed ahead of an Annual General Meeting (AGM). The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the AGM. While it is a notice, the depth of the agenda and proposals suggests it is the primary material for the meeting, fitting AGM-R better than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2023-04-03 Swedish
Notice to attend the Annual General Meeting of BioGaia AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "Notice to attend the Annual General Meeting of BioGaia AB (publ)" and details the date, time, location, right to participate, agenda items (including election of directors, approval of reports, and dividend proposals), and specific proposals for resolutions to be voted upon at the AGM. This content perfectly matches the definition of materials shared during an Annual General Meeting. Therefore, the classification is AGM-R.
2023-04-03 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.